Doctors who perform in vitro fertilization typically rely on a visual assessment of the embryos when deciding which ones to transfer into the uterus, but two-thirds of such embryos fail to implant. A new test analyzes the proteins and small-molecule metabolites in the fluid surrounding each embryo and compares the resulting metabolic profile with that of a healthy embryo. The test improves implantation rates up to 30 percent. That means doctors can transfer fewer embryos, reducing the chances of an undesired multiple pregnancy.
Courtesy of Molecular Biometrics
Cost: $30,000 to $50,000 for the testing system in the U.S. market. (Tests will not add appreciably to the typical cost of $12,000 to $15,000 for an IVF treatment.)
Availability: Now in the U.K., Australia, Japan, Ireland, and Greece; seeking FDA approval in the U.S.
Company: Molecular Biometrics
Other products in this section:
Become an MIT Technology Review Insider for in-depth analysis and unparalleled perspective.Subscribe today
Subscribe to Continue Reading
Uh oh–you've read all of your free articles for this month.
Software Predicts Cognitive Decline Using Brain Images
Spotting people most at risk of developing Alzheimer’s is a difficult task. Now a neural network can identify those likely to be diagnosed in the next three years.
Deep Learning Is a Black Box, but Health Care Won’t Mind
New algorithms are able to diagnose disease as accurately as expert physicians.
Smartphone-Controlled Cells Could Pump Insulin for Diabetics
Researchers used optogenetics and a mobile app to stimulate cells that were designed to produce insulin in diabetic mice.